After-Hours Earnings Report for November 12, 2025 : CSCO, MFC, FLUT, PAAS, ASND, TTEK, CLBT, CELC, GRAL, DLO, LB, WBTN

On November 12, 2025, several companies are slated to report earnings, presenting a mixed outlook based on analyst consensus. Cisco Systems (CSCO) and Flutter Entertainment (FLUT) are projected for strong EPS growth of 6.67% and 30.77% respectively, with both having consistently surpassed prior expectations. In contrast, Manulife Financial (MFC) and Cellebrite DI (CLBT) face more modest or declining EPS forecasts, with MFC having recently missed estimates. Notably, many of the reporting firms, including Pan American Silver (PAAS) and DLocal (DLO), exhibit P/E ratios that suggest higher future earnings growth compared to their industry averages, indicating potential investment opportunities or valuation considerations.

Analysis

Several companies are scheduled to report earnings on November 12, 2025, presenting a varied landscape. Cisco Systems (CSCO) and Flutter Entertainment (FLUT) stand out with strong consensus EPS growth forecasts of 6.67% and 30.77% respectively, both having consistently beaten expectations in the past year. Pan American Silver (PAAS) and DLocal (DLO) also show robust historical performance, beating consensus in three of the last four quarters.

Conversely, Manulife Financial (MFC) and Cellebrite DI (CLBT) face more cautious outlooks; MFC missed its last two quarters by up to -2.82%, while CLBT projects a 9.09% EPS decrease and missed Q4 2024 by -12.5%. LandBridge Company (LB) shows an exceptional 885.71% YoY EPS increase but has also missed consensus in its last two reports, with the latest by -38.46%.

Many firms, including CSCO, FLUT, PAAS, DLO, CLBT, and MFC, exhibit higher Price-to-Earnings (P/E) ratios compared to their industry averages, implying expectations for superior future earnings growth. However, Tetra Tech (TTEK) has a P/E of 21.19 against an industry average of 30.40, suggesting potentially lower relative growth. Biomedical firms like Ascendis Pharma (ASND), Celcuity (CELC), and GRAIL (GRAL) continue to report negative EPS, reflecting their developmental stages.

The overall market sentiment for this earnings cohort is mixed, with a neutral tone and a low to moderate market impact score of 0.25. This indicates that while individual company results may drive significant stock movements, the collective impact on broader market indices is not expected to be substantial.

Key Decisions for Investors

• Consider companies with strong historical beats and positive EPS growth like Cisco Systems (CSCO) and Flutter Entertainment (FLUT) for potential upside, while monitoring their P/E ratios relative to implied growth.
• Exercise caution with companies like Manulife Financial (MFC) and Cellebrite DI (CLBT) due to recent earnings misses or negative EPS growth forecasts, despite some P/E ratios implying higher future growth.
• Evaluate the justification for high P/E ratios in companies like LandBridge (LB) against their recent earnings miss history, and assess if Tetra Tech (TTEK)'s lower relative P/E offers a value opportunity.
• Approach biomedical firms such as Ascendis Pharma (ASND), Celcuity (CELC), and GRAIL (GRAL) with a long-term, high-risk investment perspective, focusing on pipeline developments rather than immediate profitability.